Category: Regional

Keeping Patients HIV-Free

South San Francisco, CA   December 1, 2017   by Anna Fiddler, Kaiser Permanente Through providing easy access to medication, fostering community, and offering telehealth opportunities, Kaiser Permanente Northern California is keeping members free from HIV. Pictured above, Truvada, a…

Phase III IMpower150 Study Showed Genentech’s Tecentriq (Atezolizumab) and Avastin (Bevacizumab) Plus Chemotherapy Significantly Reduced the Risk of Disease Worsening or Death in the Initial Treatment of People with a Type of Advanced Lung Cancer

South San Francisco, CA  November 29, 2017 Genentech Press Release – Data will be submitted to health authorities globally, including the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) – SOUTH SAN FRANCISCO, CA — 2017-11-19 00:00:00 Genentech,…